Read + Share
Amedeo Smart
Independent Medical Education
Nopsopon T, Barrett NA, Phipatanakul W, Laidlaw TM, et al. Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy 2024 Jan 2. doi: 10.1111/all.16002.PMID: 38164813
Email
LinkedIn
Facebook
Twitter
Privacy Policy